Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Institutes of Biotechnology Malaysia (NIBM) is a premier government-linked organization under the Ministry of Science, Technology and Innovation (MOSTI) that oversees three major biotechnology institutes: the Agro-Biotechnology Institute (ABI), the Malaysian Institute of Pharmaceuticals and Nutraceuticals (I-PHARM), and the Malaysia Genome and Vaccine Institute (MGVI). NIBM focuses on translating biotechnology research into commercial applications across the healthcare, agriculture, and industrial sectors. The organization plays a critical role in Malaysia's National Biotechnology Policy, driving innovation in vaccine development, genomics, and natural product discovery. Through its constituent institutes, NIBM provides high-end R&D services, infrastructure, and collaborative opportunities for both local and international partners. It operates as a Company Limited by Guarantee, bridging the gap between academic research and industrial bioeconomy needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Institutes of Biotechnology Malaysia.